Park, Ben Ho
- Vanderbilt University Medical Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #391
- Program Leader
- Top 5% Funded
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7.7M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#391
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Park, Ben Ho as a PI. Multi-PI records show the full award amount for context.
- $7.3Maward amount
- 3P30CA068485-28S1P30Contact PIAccelerated Aging and Anal Cancer Risk among People Living with HIV$257.2Kaward amount
- 5R01CA214494-06R01Contact PIMolecular Complete Response in Blood as a Predictor for a Pathologic Complete Response after Neoadjuvant Therapy fo Breast Cancer$145Kaward amount
Award organization
Organizations that administered FY2023 awards listing Park, Ben Ho as a PI.
FY2023 award administered by Vanderbilt University Medical Center (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardVanderbilt University Medical Center
- 2009$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016R01 Grant Holder
- 2018$2M Cumulative Funding
- 2018Program/Center Grant Leader
- 2021$5M Cumulative Funding
- 2021$10M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #374
- 2021Entered Top 25% NationallyRanked #374
- 2021Entered Top 10% NationallyRanked #374
- 2021Entered Top 5% NationallyRanked #374
- 2023$25M Cumulative Funding